MedPath

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000838
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To evaluate the efficacy, safety, and pharmacokinetics of lamivudine (3TC) combined with zidovudine (AZT), stavudine (d4T), or didanosine (ddI) in comparison with d4T or ddI monotherapy in HIV-infected patients with no prior nucleoside therapy.

3TC may be uniquely effective in combination with AZT due to the interaction of AZT and 3TC resistance mutations. One explanation is that the M184V mutation, which confers resistance to 3TC, suppresses AZT resistance. This benefit of 3TC may not extend to combination therapy with other nucleoside analogs.

Detailed Description

3TC may be uniquely effective in combination with AZT due to the interaction of AZT and 3TC resistance mutations. One explanation is that the M184V mutation, which confers resistance to 3TC, suppresses AZT resistance. This benefit of 3TC may not extend to combination therapy with other nucleoside analogs.

Patients are randomized to either a ddI limb or d4T limb, then randomized a second time to one of six treatment arms, as follows: ddI alone, d4T alone, 3TC/AZT (on both ddI and d4T limbs), 3TC/ddI, and 3TC/d4T. Treatment is given for 48 weeks. At study week 24, patients on monotherapy will have 3TC added to their regimen (in a blinded fashion).

PER AMENDMENT 10/18/96: A treatment extension phase has been added to the study design in order to allow subjects who complete 48 weeks of therapy to remain on their same blinded treatment until approximately 2 months after the last enrolled subject completes 48 weeks on the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
256
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Stanford CRS

🇺🇸

Palo Alto, California, United States

Santa Clara Valley Med. Ctr.

🇺🇸

San Jose, California, United States

San Mateo County AIDS Program

🇺🇸

San Mateo, California, United States

St. Louis ConnectCare, Infectious Diseases Clinic

🇺🇸

Saint Louis, Missouri, United States

Washington U CRS

🇺🇸

Saint Louis, Missouri, United States

SUNY - Buffalo, Erie County Medical Ctr.

🇺🇸

Buffalo, New York, United States

Beth Israel Med. Ctr. (Mt. Sinai)

🇺🇸

New York, New York, United States

NYU Med. Ctr., Dept. of Medicine

🇺🇸

New York, New York, United States

Univ. of Rochester ACTG CRS

🇺🇸

Rochester, New York, United States

Carolinas HealthCare System, Carolinas Med. Ctr.

🇺🇸

Charlotte, North Carolina, United States

Puerto Rico-AIDS CRS

🇵🇷

San Juan, Puerto Rico

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

UCLA CARE Center CRS

🇺🇸

Los Angeles, California, United States

Cook County Hosp. CORE Ctr.

🇺🇸

Chicago, Illinois, United States

Rush Univ. Med. Ctr. ACTG CRS

🇺🇸

Chicago, Illinois, United States

Weiss Memorial Hosp.

🇺🇸

Chicago, Illinois, United States

Northwestern University CRS

🇺🇸

Chicago, Illinois, United States

Johns Hopkins Adult AIDS CRS

🇺🇸

Baltimore, Maryland, United States

Beth Israel Deaconess Med. Ctr., ACTG CRS

🇺🇸

Boston, Massachusetts, United States

Regional Center for Infectious Disease, Wendover Medical Center CRS

🇺🇸

Greensboro, North Carolina, United States

MetroHealth CRS

🇺🇸

Cleveland, Ohio, United States

Hosp. of the Univ. of Pennsylvania CRS

🇺🇸

Philadelphia, Pennsylvania, United States

University of Washington AIDS CRS

🇺🇸

Seattle, Washington, United States

Queens Med. Ctr.

🇺🇸

Honolulu, Hawaii, United States

Univ. of Hawaii at Manoa, Leahi Hosp.

🇺🇸

Honolulu, Hawaii, United States

Alabama Therapeutics CRS

🇺🇸

Birmingham, Alabama, United States

Ucsd, Avrc Crs

🇺🇸

San Diego, California, United States

Indiana Univ. School of Medicine, Infectious Disease Research Clinic

🇺🇸

Indianapolis, Indiana, United States

Univ. of Miami AIDS CRS

🇺🇸

Miami, Florida, United States

Methodist Hosp. of Indiana

🇺🇸

Indianapolis, Indiana, United States

University of Colorado Hospital CRS

🇺🇸

Aurora, Colorado, United States

Unc Aids Crs

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath